SpyGlass Pharma, Inc. (SGP) stock
SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$30.43−0.35 (-1.14%)
Close on Nov 20, 2026Market cap $1.02BP/E –Yield –
SpyGlass Pharma net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -$39.87M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$39.87M | – |
| FY2024 | Dec 31, 2024 | -$29.16M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$19.86M | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.82M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.68M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.82M | – |
See a number that looks wrong?